drugset / Trial / NCT02126358
Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the efficacy and safety of the fix-dose combination therapy with Gemigliptin 50mg and Rosuvastatin 20mg with type 2 diabetes and dyslipidemia
Timeline
- Start
- 2014-05
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemigliptin | Small molecule | 50 mg | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |